{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:56Z","timestamp":1791843236113,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00444"],"award-info":[{"award-number":["PI17\/00444"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bone.2022.116483","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T20:40:51Z","timestamp":1656880851000},"page":"116483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases"],"prefix":"10.1016","volume":"162","author":[{"given":"Susana","family":"Jurado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Par\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Combalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Monegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Gua\u00f1abens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2022.116483_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","author":"Menon","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bone.2022.116483_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","author":"Gua\u00f1abens","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bone.2022.116483_bb0015","doi-asserted-by":"crossref","DOI":"10.1053\/jhep.2002.36357","article-title":"Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry","author":"Guichelaar","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bone.2022.116483_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/8756-3282(93)90310-7","article-title":"Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis","author":"Hodgson","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116483_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840070127","article-title":"Low bone turnover state in primary biliary cirrhosis","author":"Stellon","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.bone.2022.116483_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/0016-5085(88)90438-6","article-title":"Metabolic bone disease in primary biliary cirrhosis at presentation","author":"Mitchison","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bone.2022.116483_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","author":"Janes","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2022.116483_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2362.2009.02230.x","article-title":"Lithocholic acid downregulates vitamin D effects in human osteoblasts","author":"Ruiz-Gasp\u00e0","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bone.2022.116483_bb0045","article-title":"Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases","author":"Ruiz-Gasp\u00e0","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bone.2022.116483_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14630","article-title":"Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis","author":"Ruiz-Gasp\u00e0","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.bone.2022.116483_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/liv.12153","article-title":"Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells","author":"Dubreuil","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.bone.2022.116483_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12355","article-title":"Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis","author":"Ruiz-Gasp\u00e0","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bone.2022.116483_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2014.06.001","article-title":"Osteoclasts: more than \u201cbone eaters\u201d","author":"Charles","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bone.2022.116483_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2022.116483_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2008.01.011","article-title":"Osteoclast receptors and signaling","author":"Del Fattore","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2022.116483_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.03.010","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","author":"McDonald","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bone.2022.116483_bb0085","article-title":"Factors that affect the osteoclastogenesis of RAW264.7 cells","year":"2017","journal-title":"J. Biochem. Anal. Stud."},{"key":"10.1016\/j.bone.2022.116483_bb0090","article-title":"Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells","author":"Song","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2022.116483_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","author":"Mattick","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2022.116483_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00375","article-title":"MicroRNAs: key regulators to understand osteoclast differentiation?","author":"Lozano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2022.116483_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115757","article-title":"miRNAs in osteoclast biology","author":"Weivoda","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116483_bb0110","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7906","article-title":"Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer","author":"Shamanna","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bone.2022.116483_bb0115","first-page":"164","article-title":"Evaluation of jaundice in adults","volume":"95","author":"Fargo","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bone.2022.116483_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bone.2022.116483_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/ar3325","article-title":"MicroRNA biogenesis and regulation of bone remodeling","author":"Kapinas","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2022.116483_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/ijos.2015.22","article-title":"The role of microRNAs in bone remodeling","author":"Jing","year":"2015","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.bone.2022.116483_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/15476286.2014.996462","article-title":"The role of microRNAs in osteoclasts and osteoporosis","author":"Tang","year":"2014","journal-title":"RNA Biol."},{"key":"10.1016\/j.bone.2022.116483_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840040101","article-title":"Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia","author":"Cuthbert","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.bone.2022.116483_bb0145","doi-asserted-by":"crossref","DOI":"10.1359\/jbmr.2003.18.12.2190","article-title":"Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease","author":"Guichelaar","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116483_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/635126","article-title":"Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study","author":"Minuk","year":"2009","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.bone.2022.116483_bb0155","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M805280200","article-title":"Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption","author":"Wilson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2022.116483_bb0160","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.2014.15.1.133","article-title":"Regulation of matrix metalloproteinase-9 protein expression by 1\u03b1, 25-(OH)2D3 during osteoclast differentiation","author":"Gu","year":"2014","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.bone.2022.116483_bb0165","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-10-311415","article-title":"A microRNA expression signature of osteoclastogenesis","author":"Sugatani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bone.2022.116483_bb0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0915022107","article-title":"miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate","author":"Mann","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2022.116483_bb0175","article-title":"MiR-21 promotes osteoclastogenesis through activation of PI3K\/Akt signaling by targeting Pten in RAW264.7 cells","author":"Wang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bone.2022.116483_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115105","article-title":"Serum microRNAs as novel biomarkers for osteoporotic vertebral fractures","author":"Zarecki","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116483_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.1845","article-title":"MiR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B","author":"Cheng","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116483_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s00508-016-1141-3","article-title":"MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women","author":"Bedene","year":"2016","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.bone.2022.116483_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2175","article-title":"Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures","author":"Seeliger","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116483_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115787","article-title":"Circulating miRNAs in bone health and disease","author":"Grillari","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116483_bb0205","article-title":"Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?","author":"Lindor","year":"1995","journal-title":"Hepatology"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:03:06Z","timestamp":1757613786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":41,"alternative-id":["S8756328222001600"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116483","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116483"}}